Toggle navigation
Home
Search
Services
Blog
Contact
About
Pediatric Hydroxyurea Phase III Clinical Trial
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Metaorganismal TMAO pathway driving scleroderma pathogenesis: novel gene-environment interaction paradigm and therapeutic target
Neural and Mobile Assessment of Behavior Change Among Problem Drinkers
Role of O-glycosylation in Animal Development
Selenium-Derivatized Nucleic Acids (SENA) for Phasing, Crystallization and X-Ray
Computer Aided Analysis Of Electrocardiography
Recently added grants:
The Impact of Telestroke on Patterns of Care and Long-Term Outcomes
High throughput screen for discovery of N-acetyltransferase 8 Like (NAT8L) inhibitors
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
Subversion of Syndecan-1 Functions in Listeriosis
Chromosome scale genome assemblies for Culex pipiens mosquitoes
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research and Development Contracts (N01)
Project #
N01HB07155-16-0-1
Application #
7574917
Study Section
Project Start
2000-09-01
Project End
2009-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/ St. Jude Children's Research Hospital
$456,619
NIH 2007
N01 HL
Pedriatric Hydroxyurea Phase III Clinical Trial Clinical
Wang, Winfred C. /
$496,007
NIH 2007
N01 HL
Pediatric Hydroxyurea Phase III Clinical Trial
/
Comments
Be the first to comment on this grant